Nebraska Health Information Initiative CEO Deb Bass said the agency is trying to identify and avoid adverse medical effects to reduce readmissions.
January 31, 2018
Nebraska is the first state to require reporting of all dispensed prescription drugs to the Prescription Drug Monitoring Program.
Nebraska Health Information Initiative CEO Deb Bass said the move could save lives – not only for those taking opioids, but potentially for anyone prescribed drugs.
“We’re after those adverse medical effects,” Bass said. “Often readmissions are connected to improper medication usage, or they didn’t get their medications filled. They didn’t take the medication as they were supposed to. There are also individuals that have drug-drug interaction and they end up being re-hospitalized.”